This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Starting your retirement planning now can lead to a more secure financial future. Discover the reasons to begin your journey today.
27,547 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
SpaceX is eyeing a historic IPO. This guide explains the spacex date: what investors should watch, how pricing could ...
ServiceNow sprinted higher on Friday as AI and automation headlines fueled optimism. This piece breaks down the catal...
As crude prices rise, Occidental Petroleum trims its 2026 capital spending. This deep dive explains what the move mea...
President Trump hikes global tariffs to 15% following a Supreme Court ruling, triggering cost fears for businesses an...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
Ethereum and Solana are trading well off their peaks as upgrades loom. The market is debating which will hit a new AT...
As the Fed began cutting rates, investors wondered if floating rate loans could still shield income portfolios. A clo...
Dream Finders’ bid for Beazer has evolved into a live governance case, testing board discretion against shareholder r...
Three leading tech ETFs battle for AI-era glory. This story breaks down Nvidia exposure, valuation, and risk to answe...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...